<DOC>
	<DOCNO>NCT01609348</DOCNO>
	<brief_summary>This study test use venlafaxine treat depression Alzheimer 's Disease . Venlafaxine work increase natural substance brain ( serotonin norepinephrine ) help maintain mental balance . Alzheimer 's disease ( AD ) commonest neurodegenerative disease age cause major financial emotional burden patient , family caregiver , society . Depression common symptom AD , affect many 50 % patient illness . Depression AD ( Alzheimer 's disease ) contribute greatly patient disability caregiver distress . Neither psychosocial intervention psychotropic medication proven effective date treatment depression AD.Venlafaxine approve U.S. Food Drug Administration ( FDA ) treatment major depression know whether help depression Alzheimer 's Disease .</brief_summary>
	<brief_title>Venlafaxine Depression Alzheimer 's Disease ( DIADs-3 )</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<criteria>Dementia due Alzheimer 's disease Diagnostic Statistical Manual Diploma Social Medicine ( DSM ) IV ( TR ) criterion ( 90 ) , MiniMental State Exam ( MMSE ) ( 82 ) score 1026 inclusive ; Depression define National Institute Mental Health ( NIMH ) Consensus Criteria , Clinical Dementia Rating Scale 1 `` mild '' 2 `` moderate '' . Ratings 3 `` severe '' exclude many instrument lack validity presence severe cognitive impairment , particularly language deficit . Sufficiently good health treat use study protocol usual care circumstance ; Patient surrogate caregiver provide informed consent participation study ; A caregiver available spends least 10 hour per week patient , supervise care , willing accompany patient study visit provide information patient . Female participant must least 2 year post menopause surgically sterilize . Exclusion Criteria Presence brain disease might otherwise fully explain presence dementia , stroke , Parkinson 's disease , traumatic brain injury , multiple sclerosis , similar neurologic disease ; Clinically significant psychosis require antipsychotic treatment ; Treatment venlafaxine contraindicate opinion attend psychiatrist , example prior history dangerous unacceptable side effect treat venlafaxine ; Failure treatment venlafaxine past depression convincing evidence `` good trial , '' example 8 week high tolerate dose ; Treatment condition medication would prohibit safe concurrent use venlafaxine ( specifically include systolic blood pressure &gt; 180 mm Hg diastolic blood pressure &gt; 100 mm Hg ) ; Diagnosis congenital long QT syndrome The patient require psychiatric hospitalization depression suicidal ; Initiation , discontinuation dose change cholinesterase inhibitor memantine use within 4 week prior screen .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Depression</keyword>
	<keyword>Alzheimer 's Disease</keyword>
</DOC>